1 month Amgen stock falls as analysts mull over weight loss drug’s bone density data CNBC

Analysts cited data from a phase one study showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Amgen (AMGN)

1 month Amgen stock falls as analysts mull over weight loss drug’s bone density data CNBC

2 days Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks

2 days Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks

5 days Amgen stock gains on Novo Nordisk’s weightloss drug blunder FXStreet

5 days Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. Investor's Business Daily

1 week Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

1 week Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen Investor's Business Daily

2 weeks Why Amgen (AMGN) is a Top Growth Stock for the Long-Term Zacks

2 weeks Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks

2 weeks Here’s Why Amgen (AMGN) is a Strong Value Stock Zacks

2 weeks Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks

2 weeks The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks

3 weeks Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Seeking Alpha

3 weeks The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem Zacks

3 weeks Top Stock Reports for Amgen, Eaton & Enzo Biochem Zacks

3 weeks Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha

3 weeks Amgen Stock Falls 12% in a Month: Should You Buy the Dip? Zacks

4 weeks Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger The Wall Street Journal

4 weeks Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Zacks

4 weeks Is Amgen Stock Still a Buy After an Unexpected Reveal of Data? Yahoo Finance

4 weeks AMGN Stock Down Despite Strong Data From Obesity Drug Study Zacks

4 weeks Amgen’s Phase 2 Results Were Not Bad, Don’t Let Mr. Market Fool You Seeking Alpha

4 weeks Amgen: Checks All The Wrong Boxes Seeking Alpha

4 weeks Final Trade: JWN, IWM, GCO, AMGN YouTube

4 weeks Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher Raymond YouTube

4 weeks Amgen stock sinks as weightloss drug fails to impress FXStreet

4 weeks Amgen: MariTide Underwhelms, But There Are Ways To Win Seeking Alpha

4 weeks Chart of the Day: Amgen YouTube

4 weeks Cramer’s Stop Trading: Amgen YouTube

4 weeks Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know. Yahoo Finance

4 weeks Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity Treatment Investor's Business Daily

4 weeks Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know. Yahoo Finance

4 weeks Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau YouTube

4 weeks These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and More Yahoo Finance

1 month Why Amgen (AMGN) is a Top Value Stock for the Long-Term Zacks

1 month Amgen Sells Off: Keep Calm And Buy The Dip Seeking Alpha

1 month Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks

1 month Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcare FXStreet

1 month Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate Zacks

1 month Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript) Seeking Alpha

1 month Trade Tracker: Joe Terranova sells Amgen and buys XBI YouTube

1 month Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? Investor's Business Daily

1 month Amgen dismisses bone density concerns related to its new weight-loss drug Investing.com

1 month Amgen sinks as Cantor flags issues with obesity drug YouTube

1 month Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity Shot Investor's Business Daily

2 months Big Pharma’s Obesity Bonanza Faces New Tests The Wall Street Journal

2 months Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market Seeking Alpha

2 months Analyst Report: AMGEN Inc. Yahoo Finance

2 months Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHC Yahoo Finance

2 months Amgen Inc. (AMGN) Q3 2024 Earnings Call Transcript Seeking Alpha

2 months Amgen Inc. 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha

The Stock Market News